Pharmacogenomics of CYP2D6: Molecular genetics

  • TEH Lay Kek
    Pharmacogenomics Centre (PROMISE), Faculty of Pharmacy, Universiti Teknologi MARA
  • BERTILSSON Leif
    Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University, Hospital-Huddinge, Karolinska Institutet

書誌事項

タイトル別名
  • Pharmacogenomics of CYP2D6: Molecular Genetics, Interethnic Differences and Clinical Importance

この論文をさがす

説明

  CYP2D6 has received intense attention since the beginning of the pharmacogenetic era in the 1970s. This is because of its involvement in the metabolism of more than 25% of the marketed drugs, the large geographical and inter-ethnic differences in the genetic polymorphism and possible drug-induced toxicity. Many interesting reviews have been published on CYP2D6 and this review aims to reinstate the importance of the genetic polymorphism of CYP2D6 in different populations as well as some clinical implications and important drug interactions.<br>

収録刊行物

被引用文献 (9)*注記

もっと見る

参考文献 (160)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ